Client News / 08.22.2012 / FDA Clears Wireless ViSi® Mobile Patient Monitoring System Aimed at Enhancing Patient Safety for Ambulatory Hospital Patients

SAN DIEGO, Aug. 21, 2012 – Sotera Wireless, Inc. announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its full ViSi Mobile® System and is commencing sales to hospitals nationwide. The ViSi Mobile System, as approved, uses WiFi (802.11) wireless technology for transmission of patients’ vital signs, keeping hospital clinicians connected to their patients, whether patients are in bed or up and moving around. Earlier this year, Sotera announced 510(k) clearance for its first generation ViSi Mobile Monitor, which encompasses the stand-alone device portion of the system that for the first time provides continuous monitoring of all the core vital signs on a patient worn platform.

Read the Full Press Release

Client News / 07.10.2012 / Cancer Cell Article Demonstrates First Definitive Evidence for Targeting of Pol I as New Approach to Cancer Therapy

San Diego, July 10, 2012 – Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors.  Published today in Cancer Cell, the findings show that Cylene’s Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.

Read the Full Press Release

Client News / 06.27.2012 / New Way for Life Science Firms to Find Partners

SAN DIEGO (June 27, 2012) – As a response to the extraordinary growth of outsourcing in the life science industry and the expanding number of contract research organizations (CROs) in Southern California, BIOCOM launched a new CRO website (www.biocomcro.org) as a way to inform our life science members of the vast array of services that our local CRO community has to offer. One of BIOCOM’s members, 321 Medical Launch, designed and developed the website.

Read the Full Press Release

Client News / 06.12.2012 / Cutting Edge Naviscan PEM Research Presented At SNM 2012

Miami, FL – June 12, 2012 – Several groundbreaking studies on the Naviscan PET scanner, the breast application for which is Positron Emission Mammography (PEM), were presented this week at the Annual Meeting of the Society of Nuclear Medicine (SNM) in Miami, Florida.  Researchers from the Johns Hopkins University, Thomas Jefferson University, Boston University and University of Washington presented abstracts focusing on use of novel radiotracers, new clinical applications as well as low-dose imaging with PEM.

Read the Full Press Release

Client News / 06.05.2012 / After Capturing the U.S. Market, Frost & Sullivan Recognizes Naviscan’s Pioneering Organ-Specific PET Scanner’s Potential in Europe

MOUNTAIN VIEW, Calif. — June 6, 2012 — Based on its recent analysis of the organ-specific molecular imaging market, Frost & Sullivan recognizes Naviscan Inc. (Naviscan) with the 2012 European Frost & Sullivan Award for Product Quality Leadership for its organ-specific PET scanner. With its main application in Positron Emission Mammography (PEM), the product offers multiple benefits to the customer over competing products.

Read the Full Press Release

Client News / 05.18.2012 / BIOCOM’s Medical Device & Diagnostics Expo A Big Hit

San Diego – May 17, 2012 – BIOCOM’s 6th Annual Media Device & Diagnostics Expo took place yesterday, bringing together the region’s leading medical innovations with venture capitalists, industry influencers, and a host of individuals dedicated to the success of the med tech industry.  The event was a huge success, and attendees from all over were able to experience, first hand, what the future holds in the hottest lifesaving technologies that exist today.

Read the Full Press Release

Client News / 04.18.2012 / Sotera Wireless Reports FDA Clearance Of ViSi Mobile™ System

SAN DIEGO – April 18, 2012 – Sotera Wireless, Inc. announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the ViSi Mobile™ System, a new continuous vital signs monitoring system for use in hospitals. The clearance represents a major milestone in Sotera’s effort to develop a comprehensive wireless patient monitoring system, particularly for ambulatory hospital patients.

Read the Full Press Release

Client News / 04.03.2012 / Cylene Builds on Success, Presents Second CK2 Inhibitor at AACR Meeting

San Diego, April 3, 2012 – Cylene Pharmaceuticals, Inc. is developing a second generation compound, building on the success of its first-in-class CK2 inhibitor, CX-4945, the company announced today. Dr. Denis Drygin, Cylene’s VP of Biology, will profile the small molecule CK2 inhibitor, CX-8184, at the 2012 American Association for Cancer Research (AACR) annual meeting, held from March 31 to April 4 in Chicago, IL. The presentation will highlight the agent’s potent and sustained suppression of protein kinase CK2, its impact on multiple key pathways and the potential of CK2 inhibitors in the combination treatment of cancer.

Read the Full Press Release

Client News / 03.06.2012 / LOW DOSE PEM RESULTS PRESENTED AT ECR 2012

Vienna, Austria – March 1, 2012 – Presented today at the European Congress of Radiology (ECR) in Vienna, Austria, researchers from Boca Raton Regional Hospital in Florida showed that FDG dose for Positron Emission Mammography (PEM) may be reduced by up to 50% without impacting sensitivity.  Several clinical cases utilizing an optimized dose were presented as part of this abstract.

Read the Full Press Release

Client News / 03.06.2012 / Cooper Tire and Yulex Corporation Announce Joint Development Agreement

FINDLAY, OHIO and PHOENIX, ARIZONA, FEBRUARY 29, 2012 – COOPER TIRE & RUBBER COMPANY (NYSE: CTB) and YULEX CORPORATION announced today that they have entered into an agreement for the joint evaluation and development of guayule polymers and resins for tire applications. Under this agreement, Cooper will provide advanced polymer and materials science expertise, and utilize its design, development and testing capabilities as part of this project. Yulex provides experience with the development and production of advanced engineered biopolymers from the guayule plant. Terms of the agreement are not being disclosed.

Read the Full Press Release

Client News / 01.05.2012 / YULEX CORPORATION ANNOUNCES MORE PATENT PROTECTION WORLDWIDE FOR ITS RUBBER PRODUCTION

Phoenix AZ, January 5, 2012 – Yulex Corporation announced today that patent offices in the United States, Europe, Mexico and South Africa have granted the Company patents covering its commercial methods for latex and resin extraction from the guayule plant, a desert shrub. Yulex has patent protection throughout Europe, particularly in those regions with climates suitable for growing guayule including Greece, Cyprus, Spain, France, Italy and Portugal.

Read the Full Press Release
  • Sort by Year:
  • 2012
  • 2011